Xeris Biopharma Holdings, Inc. (XERS): A Bull Case Theory

We came across a bullish thesis on Xeris Biopharma Holdings, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research and Rudy Does Research. In this article, we will summarize the bulls’ thesis on XERS. Xeris Biopharma Holdings, Inc.'s share was trading at $7.05 as of December 15th. XERS’s forward P/E was 64.10 according to Yahoo Finance. create jobs 51/Shutterstock.com Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercial ...